Skip navigation

Merck & Co. Inc.

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$39,807
Revenue Growth (%)0.78%
Net Income (US$ Millions)$3,920
Earnings Per Share (US$)$1.41
EPS Growth Rate (%)-9.62%
Profit Margin9.85%
Total Equity (US$ Millions)$40,088
Return on Equity (%)8.77%
Long Term Debt (US$ Millions)$24,274
Debt To Equity Ratio (%)0.61%
Total Assets (US$ Millions)$95,377
Current Assets (US$ Millions)$30,614
Current Liabilities (US$ Millions)$17,204
Cost of Goods Sold (US$ Millions)$13,891
Inventory Turnover2.90